News
Hosted on MSN11mon
The inhibitory effect of miR-377 on prostate cancer cellsThe team concludes, "Taken together, these results unveil the inhibitory role of miR-377 in MYC function within PCa, thereby suggesting its potential as a therapeutic target for the treatment of ...
Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...
StockStory.org on MSN1d
Mirion (NYSE:MIR) Surprises With Q1 SalesRadiation safety company Mirion (NYSE:MIR) announced in Q1 CY2025, with sales up 4.9% year on year to $202 million. Its ...
To answer this question, they extracted EVs from a breast cancer cell line that exhibits a tendency to migrate to the brain and analyzed their microRNA contents. 5 They found a significant increase in ...
12d
News Medical on MSNThe dual role of microRNAs in lung cancer progression and suppressionLung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...
Mirion Technologies Inc (MIR) reports impressive growth in cash flow and orders, despite challenges in the medical segment and market uncertainties.
Global disparities exist in the burden of cervical cancer. Only 11 out of the 185 countries and regions reported an age-standardized incidence rates (ASIR) lower than the World Health Organization’s ...
Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small ...
StockStory.org on MSN13d
1 Services Stock to Own for Decades and 2 to Think Twice AboutBusiness services providers thrive by solving complex operational challenges for their clients, allowing them to focus on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results